Pre‐Plated Cell Lines for ADMETox Applications in the Pharmaceutical Industry

Francisco M. Torres1, Zsolt Sáfár1, Maria A. Vázquez‐Sánchez2, Anita Kurunczi3, Emese Kis3, Rémi Magnan3, Márton Jani3, Oriol Nicolás4, Péter Krajcsi4

1 shared first authorship, 2 Bioinvitro Division, Leitat Technological Center, Terrassa, Spain, 3 Solvo Biotechnology, Budaörs, Hungary, 4 shared senior authorship
Publication Name:  Current Protocols in Toxicology
Unit Number:  Unit 23.8
DOI:  10.1002/0471140856.tx2308s65
Online Posting Date:  August, 2015
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library

Abstract

Membrane transporters significantly modulate membrane permeability of endobiotics and xenobiotics, such as bile acids and drugs, respectively. Various in vitro methods have been established for both ATP‐binding cassette (ABC) transporters to examine cellular efflux and uptake, and for solute carriers (SLC) to examine cellular uptake of substrates. Cell‐based systems are the models of choice to test drug‐transporter interactions as well as drug‐drug interactions for research and regulatory purposes, albeit, for low passive permeability substrates of ABC transporters, vesicular uptake assays are also recommended. Commercially available pre‐plated cells (e.g., immortalized or transfected) offer a useful alternative to in‐house cell culture. Three main methods are known to manufacture pre‐plated cultures: regular culture medium with vacuum seal, cryopreserved delivery, and the solid shipping media technology. The regular culture medium and the solid shipping media technologies provide ready‐to‐use models for end users. Models expressing a broad selection of transporters are available in pre‐plated formats for absorption, distribution, metabolism, excretion, and toxicity (ADMETox) studies. Conversely, the application and utility of pre‐plated cultures coupled with personal experiences have not been extensively covered in published research papers or reviews, despite availability and significant use of pre‐plated products in the pharmaceutical industry. In this overview, we will briefly describe: 1) in vitro tools commonly used for ADMETox testing; 2) methods employed in manufacturing, shipment and preparation of pre‐plated cell lines; 3) cell‐membrane barrier models currently available in pre‐plated format to reproduce passage restriction of physiological barriers to certain compounds; and 4) recommended pre‐plated cell lines overexpressing uptake transporters for ADMETox applications. © 2015 by John Wiley & Sons, Inc.

Keywords: pre‐plated cell lines; transporters; ADMETox; ABC transporters; solute carriers (SLC); permeability; regulatory studies

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Utilization of In Vitro Systems in ADMETox Testing
  • Critical Issues with Cell Work
  • Cell Work Strategies, Rationales, and Routines in the Pharmaceutical Industry
  • Technologies for Manufacturing Pre‐Plated Cells
  • Methods to Manufacture Pre‐Plated Cells
  • Logistics Considerations
  • Laboratory Requirements for End Users
  • Barrier Models
  • Uptake Transporter Overexpressing Cell Lines
  • Conclusions
  • Acknowledgments
  • Conflict of Interest
  • Literature Cited
  • Figures
  • Tables
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

Videos

Literature Cited

Literature Cited
   Anwer, M.S. and Stieger, B. 2014. Sodium‐dependent bile salt transporters of the SLC10A transporter family: More than solute transporters. Pflugers Arch. 466:77‐89. doi: 10.1007/s00424‐013‐1367‐0
   Artursson, P. and Karlsson, J. 1991. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco‐2) cells. Biochem. Biophys. Res. Commun. 175:880‐885.
   Bailey, L.A. , Hatton, D. , Field, R. , and Dickson, A.J. 2012. Determination of Chinese hamster ovary cell line stability and recombinant antibody expression during long‐term culture. Biotechnol. Bioeng. 109:2093‐2103. doi: 10.1002/bit.24485
   Balda, M.S. , Whitney, J.A. , Flores, C. , González, S. , Cereijido, M. , and Matter, K. 1996. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical‐basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J. Cell Biol. 134:1031‐1049. doi: 10.1083/jcb.134.4.1031
   Béduneau, A. , Tempesta, C. , Fimbel, S. , Pellequer, Y. , Jannin, V. , Demarne, F. , and Lamprecht, A. 2014. A tunable Caco‐2/HT29‐MTX co‐culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure. Eur. J. Pharm. Biopharm. 87:290‐298. doi: 10.1016/j.ejpb.2014.03.017
   Beery, E. , Rajnai, Z. , Abonyi, T. , Makai, I. , Bansaghi, S. , Erdo, F. , Sziraki, I. , Heredi‐Szabo, K. , Kis, E. , Jani, M. , Marki‐Zay, J. , Toth, G.K. , and Krajcsi, P. 2012. ABCG2 modulates chlorothiazide permeability—in vitro‐characterization of its interactions. Drug Metab. Pharmacokinet. 27:349‐353.
   Bentz, J. , O'Connor, M.P. , Bednarczyk, D. , Coleman, J. , Lee, C. , Palm, J. , Pak, Y.A. , Perloff, E.S. , Reyner, E. , Balimane, P. , Brannstrom, M. , Chu, X. , Funk, C. , Guo, A. , Hanna, I. , Heredi‐Szabo, K. , Hillgren, K. , Li, L. , Hollnack‐Pusch, E. , Jamei, M. , Lin, X. , Mason, A.K. , Neuhoff, S. , Patel, A. , Podila, L. , Plise, E. , Rajaraman, G. , Salphati, L. , Sands, E. , Taub, M.E. , Taur, J.S. , Weitz, D. , Wortelboer, H.M. , Xia, C.Q. , Xiao, G. , Yabut, J. , Yamagata, T. , Zhang, L. , and Ellens, H. 2013. Variability in P‐glycoprotein inhibitory potency (IC50) using various in vitro experimental systems: Implications for universal digoxin drug‐drug interaction risk assessment decision criteria. Drug Metab. Dispos. 41:1347‐1366. doi: 10.1124/dmd.112.050500
   Blais, A. , Aymard P. , and Lacour, B. 1997. Paracellular calcium transport across Caco‐2 and HT29 cell monolayers. Pflugers Arch. 434:300‐305.
   Briske‐Anderson, M.J. , Finley, J.W. , and Newman, S.M. 1997. The influence of culture time and passage number on the morphological and physiological development of Caco‐2 cells. Proc. Soc. Exp. Biol. Med. 214:248‐257. doi: 10.3181/00379727‐214‐44093
   Brown, C.D. , Sayer, R. , Windass, A.S. , Haslam, I.S. , De Broe, M.E. , D'Haese, P.C. , and Verhulst, A. 2008. Characterisation of human tubular cell monolayers as a model of proximal tubular xenobiotic handling. Toxicol. Appl. Pharmacol. 233:428‐438. doi: 10.1016/j.taap.2008.09.018
   Burckhardt, G. and Burckhardt, B.C. 2011. In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy. In Drug Transporters, Handbook of Experimental Pharmacology 201 ( M.F. Fromm and R.B. Kim , eds.) pp. 29‐104. Springer‐Verlag, Berlin doi: 10.1007/978‐3‐642‐14541‐4_2
   Busch, A.E. , Karbach, U. , Miska, D. , Gorboulev, V. , Akhoundova, A. , Volk, C. , Arndt, P. , Ulzheimer, J.C. , Sonders, M.S. , Baumann, C. , Waldegger, S. , Lang, F. , and Koepsell, H. 1998. Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol. Pharmacol. 54:342‐352.
   CFR. 2015. Code of Federal Regulations, Title 49: Transportation. http://www.ecfr.gov/cgi‐bin/text‐idx?tpl=/ecfrbrowse/Title49/49cfrv2_02.tpl.
   Choudhuri, S. , Cherrington, N.J. , Li, N. , and Klaassen, C.D. 2003. Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. Drug. Metab. Dispos. 31:1337‐1345. doi: 10.1124/dmd.31.11.1337
   Coriell, L.L. 1979. Preservation, storage, and shipment. In Methods in Enzymology, Vol. 58. ( W.B. Jakoby and I.H. Pastan , eds.) pp. 29‐36. Academic Press, New York.
   Cui, Y. , Konig, J. , and Keppler, D. 2001. Vectorial transport by double‐transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol. Pharmacol. 60:934‐943.
   De Boussac, H. , Orban, T.I. , Varady, G. , Tihanyi, B. , Bacquet, C. , Brozik, A. , Varadi, A. , Sarkadi, B. , and Aranyi, T. 2012. Stimulus‐induced expression of the ABCG2 multidrug transporter in HepG2 hepatocarcinoma model cells involves the ERK1/2 cascade and alternative promoters. Biochem. Biophys. Res. Commun. 426:172‐176. doi: 10.1016/j.bbrc.2012.08.046
   De Bruyn, T. , Sempels, W. , Snoeys, J. , Holmstock, N. , Chatterjee, S. , Stieger, B. , Augustijns, P. , Hofkens, J. , Mizuno, H. , and Annaert, P. 2014. Confocal imaging with a fluorescent bile acid analogue closely mimicking hepatic taurocholate disposition. J. Pharm. Sci. 103:1872‐1881. doi: 10.1002/jps.23933
   Degeling, M.H. , Bovenberg, M.S. , Tannous, M. , and Tannous, B.A. 2014. Gaussia luciferase‐based mycoplasma detection assay in mammalian cell culture. Methods Mol. Biol. 1098:47‐55. doi: 10.1007/978‐1‐62703‐718‐1_4
   Dehghan, A. , Kottgen, A. , Yang, Q. , Hwang, S.J. , Kao, W.L. , Rivadeneira, F. , Boerwinkle, E. , Levy, D. , Hofman, A. , Astor, B.C. , Benjamin, E.J. , van Duijn, C.M. , Witteman, J.C. , Coresh, J. , and Fox, C.S. 2008. Association of three genetic loci with uric acid concentration and risk of gout: A genome‐wide association study. Lancet 372:1953‐1961. doi: 10.1016/S0140‐6736(08)61343‐4
   Ditewig, A.C. , Cugier, D.J. , Liguori, M.J. , Yang, Y. , and Blomme, E.A.G. 2013. Transcriptomic evaluation of canine suspension‐shipped and pre‐plated hepatocytes: Comparison to liver. Toxicol. Mech. Methods 23:479‐490. doi: 10.3109/15376516.2013.796031.
   Dukes, J.D. , Whitley, P. , and Chalmers, A.D. 2011. The MDCK variety pack: Choosing the right strain. BMC Cell Biol. 12:43. doi:10.1186/1471‐2121‐12‐43
   El‐Sheikh, A.A. , van den Heuvel, J.J. , Koenderink, J.B. , and Russel, F.G. 2008. Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4. Br. J. Pharmacol. 155:1066‐1075. doi: 10.1038/bjp.2008.343
   EMA. 2012. Guideline on the Investigation of Drug Interactions. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/07/WC500129606.pdf
   Erdman, A.R. , Mangravite, L.M. , Urban, T.J. , Lagpacan, L.L. , Castro, R.A. , de la Cruz, M. , Chan, W. , Huang, C.C. , Johns, S.J. , Kawamoto, M. , Stryke, D. , Taylor, T.R. , Carlson, E.J. , Ferrin, T.E. , Brett, C.M. , Burchard, E.G. , and Giacomini, K.M. 2006. The human organic anion transporter 3 (OAT3; SLC22A8): Genetic variation and functional genomics. Am. J. Physiol. Renal. Physiol. 290:F905‐F912.
   FDA. 2012. Guidance for Industry. Drug interaction studies—study design, data analysis, implications for dosing, and labeling recommendations. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM292362.pdf
   Feng, B. , LaPerle, J.L. , Chang, G. , and Varma, M.V. 2010. Renal clearance in drug discovery and development: Molecular descriptors, drug transporters and disease state. Expert Opin. Drug Metab. Toxicol. 6:939‐952. doi: 10.1517/17425255.2010.482930
   Fletcher, J.I. , Haber, M. , Henderson, M.J. , and Norris, M.D. 2010. ABC transporters in cancer: More than just drug efflux pumps. Nat. Rev. Cancer 10:147‐156. doi: 10.1038/nrc2789
   Folmsbee, M. , Lentine, K.R. , Wright, C. , Haake, G. , McBurnie, L. , Ashtekar, D. , Beck, B. , Hutchison, N. , Okhio‐Seaman, L. , Potts, B. , Pawar, V. , and Windsor, H. 2014. The development of a microbial challenge test with Acholeplasma laidlawii to rate Mycoplasma‐retentive filters by filter manufacturers. PDA J. Pharm. Sci. Technol. 68:281‐296. doi: 10.5731/pdajpst.2014.00976
   Galluzzi, L. , Bravo‐San Pedro, J.M. , Vitale, I. , Aaronson, S.A. , Abrams, J.M. , Adam, D. , Alnemri, E.S. , Altucci, L. , Andrews, D. , Annicchiarico‐Petruzzelli, M. , Baehrecke, E.H. , Bazan, N.G. , Bertrand, M.J. , Bianchi, K. , Blagosklonny, M.V. , Blomgren, K. , Borner, C. , Bredesen, D.E. , Brenner, C. , Campanella, M. , Candi, E. , Cecconi, F. , Chan, F.K. , Chandel, N.S. , Cheng, E.H. , Chipuk, J.E. , Cidlowski, J.A. , Ciechanover, A. , Dawson, T.M. , Dawson, V.L. , De Laurenzi, V. , De Maria, R. , Debatin, K.M. , Di Daniele, N. , Dixit, V.M. , Dynlacht, B.D. , El‐Deiry, W.S. , Fimia, G.M. , Flavell, R.A. , Fulda, S. , Garrido, C. , Gougeon, M.L. , Green, D.R. , Gronemeyer, H. , Hajnoczky, G. , Hardwick, J.M. , Hengartner, M.O. , Ichijo, H. , Joseph, B. , Jost, P.J. , Kaufmann, T. , Kepp, O. , Klionsky, D.J. , Knight, R.A. , Kumar, S. , Lemasters, J.J. , Levine, B. , Linkermann, A. , Lipton, S.A. , Lockshin, R.A. , Lopez‐Otin, C. , Lugli, E. , Madeo, F. , Malorni, W. , Marine, J.C. , Martin, S.J. , Martinou, J.C. , Medema, J.P. , Meier, P. , Melino, S. , Mizushima, N. , Moll, U. , Munoz‐Pinedo, C. , Nunez, G. , Oberst, A. , Panaretakis, T. , Penninger, J.M. , Peter, M.E. , Piacentini, M. , Pinton, P. , Prehn, J.H. , Puthalakath, H. , Rabinovich, G.A. , Ravichandran, K.S. , Rizzuto, R. , Rodrigues, C.M. , Rubinsztein, D.C. , Rudel, T. , Shi, Y. , Simon, H.U. , Stockwell, B.R. , Szabadkai, G. , Tait, S.W. , Tang, H.L. , Tavernarakis, N. , Tsujimoto, Y. , Vanden Berghe, T. , Vandenabeele, P. , Villunger, A. , Wagner, E.F. , Walczak, H. , White, E. , Wood, W.G. , Yuan, J. , Zakeri, Z. , Zhivotovsky, B. , Melino, G. , and Kroemer, G. 2015. Essential versus accessory aspects of cell death: Recommendations of the NCCD 2015. Cell Death Differ. 22:58‐73. doi: 10.1038/cdd.2014.137
   Giacomini, K.M. , Huang, S.M. , Tweedie, D.J. , Benet, L.Z. , Brouwer, K.L. , Chu, X. , Dahlin, A. , Evers, R. , Fischer, V. , Hillgren, K.M. , Hoffmaster, K.A. , Ishikawa, T. , Keppler, D. , Kim, R.B. , Lee, C.A. , Niemi, M. , Polli, J.W. , Sugiyama, Y. , Swaan, P.W. , Ware, J.A. , Wright, S.H. , Yee, S.W. , Zamek‐Gliszczynski, M.J. , and Zhang, L. 2010. Membrane transporters in drug development. Nat. Rev. Drug Discov. 9:215‐236. doi: 10.1038/nrd3028
   Graber‐Maier, A. , Gutmann, H. , and Drewe, J. 2010. A new intestinal cell culture model to discriminate the relative contribution of P‐gp and BCRP on transport of substrates such as imatinib. Mol. Pharm. 7:1618‐1628. doi: 10.1021/mp100040f
   Hanna, J. and Hubel A. 2009. Preservation of stem cells. Organogenesis 5:134‐137. doi: 10.4161/org.5.3.9585
   Hirouchi, M. , Kusuhara, H. , Onuki, R. , Ogilvie, B.W. , Parkinson, A. , and Sugiyama, Y. 2009. Construction of triple‐transfected cells [organic anion‐transporting polypeptide (OATP) 1B1/multidrug resistance‐associated protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for analysis of the sinusoidal function of MRP3 and MRP4. Drug Metab. Dispos. 37:2103‐2111. doi: 10.1124/dmd.109.027193
   Hsiang, B. , Zhu, Y. , Wang, Z. , Wu, Y. , Sasseville, V. , Yang, W.P. , and Kirchgessner, T.G. 1999. A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver‐specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl‐CoA reductase inhibitor transporters. J. Biol. Chem. 274:37161‐37168. doi: 10.1074/jbc.274.52.37161
   Hubatsch, I. , Ragnarsson, E.G. , and Artursson, P. 2007. Determination of drug permeability and prediction of drug absorption in Caco‐2 monolayers. Nat. Protoc. 2:2111‐2119. doi: 10.1038/nprot.2007.303
   Ianculescu, A.G. , Friesema, E.C. , Visser, T.J. , Giacomini, K.M. , and Scanlan, T.S. 2010. Transport of thyroid hormones is selectively inhibited by 3‐iodothyronamine. Mol. Biosyst. 6:1403‐1410. doi: 10.1039/b926588k
   Imamura, Y. , Murayama, N. , Okudaira, N. , Kurihara, A. , Okazaki, O. , Izumi, T. , Inoue, K. , Yuasa, H. , Kusuhara, H. , and Sugiyama, Y. 2011. Prediction of fluoroquinolone‐induced elevation in serum creatinine levels: A case of drug‐endogenous substance interaction involving the inhibition of renal secretion. Clin. Pharmacol. Ther. 89:81‐88. doi: 10.1038/clpt.2010.232
   International Air Transport Association. 2015. Dangerous Goods Regulations 56th edition requirements. http://www.iata.org/whatwedo/cargo/dgr/pages/download.aspx
   Jonker, J.W. and Schinkel, A.H. 2004. Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1‐3). J. Pharmacol. Exp. Ther. 308:2‐9. doi: 10.1124/jpet.103.053298
   Kenzaoui, B.H. , Vila, M.R. , Miquel, J.M. , Cengelli, F. , and Juillerat‐Jeanneret, L. 2012. Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells. Int. J. Nanomedicine 7:1275‐1286. doi: 10.2217/nnm.12.99
   Keppler, D. 2014. The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia. Drug Metab. Dispos. 42:561‐565. doi: 10.1124/dmd.113.055772
   Kim, K.A. , Joo, H.J. , and Park, J.Y. 2011. Effect of ABCG2 genotypes on the pharmacokinetics of A771726, an active metabolite of prodrug leflunomide, and association of A771726 exposure with serum uric acid level. Eur. J. Clin. Pharmacol. 67:129‐134. doi: 10.1007/s00228‐010‐0916‐0
   Kim, M.K. and Shim, C.K. 2006. The transport of organic cations in the small intestine: Current knowledge and emerging concepts. Arch. Pharm. Res. 29:605‐616. doi: 10.1007/BF02969273
   Koepsell, H. 2004. Polyspecific organic cation transporters: Their functions and interactions with drugs. Trends Pharmacol. Sci. 25:375‐381. doi: 10.1016/j.tips.2004.05.005
   Koepsell, H. , Lips, K. , and Volk, C. 2007. Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications. Pharm. Res. 24:1227‐1251. doi: 10.1007/s11095‐007‐9254‐z.
   Konig, J. , Cui, Y. , Nies, A.T. , and Keppler, D. 2000. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am. J. Physiol. Gastrointest. Liver Physiol. 278:G156‐G164.
   Kopplow, K. , Letschert, K. , Konig, J. , Walter, B. , and Keppler, D. 2005. Human hepatobiliary transport of organic anions analyzed by quadruple‐transfected cells. Mol. Pharmacol. 68:1031‐1038. doi: 10.1124/mol.105.014605
   Krajcsi, P. 2013. Drug‐transporter interaction testing in drug discovery and development. World J. Pharmacol. 9:35‐46. doi: 10.5497/wjp.v2.i1.35
   Kullak‐Ublick, G.A. , Fisch, T. , Oswald, M. , Hagenbuch, B. , Meier, P.J. , Beuers, U. , and Paumgartner, G. 1998. Dehydroepiandrosterone sulfate (DHEAS): Identification of a carrier protein in human liver and brain. FEBS Lett. 424:173‐176. doi: 10.1016/S0014‐5793(98)00168‐9
   Kullak‐Ublick, G.A. , Ismair, M.G. , Stieger, B. , Landmann, L. , Huber, R. , Pizzagalli, F. , Fattinger, K. , Meier, P.J. , and Hagenbuch, B. 2001. Organic anion‐transporting polypeptide B (OATP‐B) and its functional comparison with three other OATPs of human liver. Gastroenterology 120:525‐533. doi: 10.1053/gast.2001.21176
   Lahoz, A. , Vila, M.R. , Fabre, M. , Miquel, J.M. , Rivas, M. , Maines, J. , Castell, J.V. , and Gomez‐Lechon, M.J. 2013. An in vitro tool to assess cytochrome P450 drug biotransformation‐dependent cytotoxicity in engineered HepG2 cells generated by using adenoviral vectors. Toxicol. In Vitro 27:1410‐1415. doi: 10.1016/j.tiv.2012.08.001
   Lee, W. , Belkhiri, A. , Lockhart, A.C. , Merchant, N. , Glaeser, H. , Harris, E.I. , Washington, M.K. , Brunt, E.M. , Zaika, A. , Kim, R.B. , and El‐Rifai, W. 2008. Overexpression of OATP1B3 confers apoptotic resistance in colon cancer. Cancer Res. 68:10315‐10323. doi: 10.1158/0008‐5472.CAN‐08‐1984
   Li, A.P. 2005. Preclinical in vitro screening assays for drug‐like properties. Drug Discov. Today Technol. 2:179‐185. doi: 10.1016/j.ddtec.2005.05.024
   Lufino, M.M. , Edser, P.A. , and Wade‐Martins, R. 2008. Advances in high‐capacity extrachromosomal vector technology: Episomal maintenance, vector delivery, and transgene expression. Mol. Ther. 16:1525‐1538. doi: 10.1038/mt.2008.156
   Maddox, C.B. , Rasmussen, L. , and White, E.L. 2008. Adapting cell‐based assays to the high throughput screening platform: Problems encountered and lessons learned. J. Lab. Autom. 13:168‐173.
   Maher, J.M. , Dieter, M.Z. , Aleksunes, L.M. , Slitt, A.L. , Guo, G. , Tanaka, Y. , Scheffer, G.L. , Chan, J.Y. , Manautou, J.E. , Chen, Y. , Dalton, T.P. , Yamamoto, M. , and Klaassen, C.D. 2007. Oxidative and electrophilic stress induces multidrug resistance‐associated protein transporters via the nuclear factor‐E2‐related factor‐2 transcriptional pathway. Hepatology 46:1597‐1610. doi: 10.1002/hep.21831
   Markowska, M. , Oberle, R. , Juzwin, S. , Hsu, C.P. , Gryszkiewicz, M. , and Streeter, A.J. 2001. Optimizing Caco‐2 cell monolayers to increase throughput in drug intestinal absorption analysis. J. Pharmacol. Toxicol. Methods 46:51‐55. doi: 10.1016/S1056‐8719(01)00161‐7
   Mita, S. , Suzuki, H. , Akita, H. , Hayashi, H. , Onuki, R. , Hofmann, A.F. , and Sugiyama, Y. 2006. Vectorial transport of unconjugated and conjugated bile salts by monolayers of LLC‐PK1 cells doubly transfected with human NTCP and BSEP or with rat Ntcp and Bsep. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G550‐556. doi: 10.1152/ajpgi.00364.2005
   Morgan, R.E. , Trauner, M. , van Staden, C.J. , Lee, P.H. , Ramachandran, B. , Eschenberg, M. , Afshari, C.A. , Qualls, C.W. Jr. , Lightfoot‐Dunn, R. , and Hamadeh, H.K. 2010. Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol. Sci. 118:485‐500. doi: 10.1093/toxsci/kfq269
   Motohashi, H. and Inui, K. 2013. Multidrug and toxin extrusion family SLC47: Physiological, pharmacokinetic and toxicokinetic importance of MATE1 and MATE2‐K. Mol. Aspects Med. 34:661‐668. doi: 10.1016/j.mam.2012.11.004
   Motohashi, H. , Sakurai, Y. , Saito, H. , Masuda, S. , Urakami, Y. , Goto, M. , Fukatsu, A. , Ogawa, O. , and Inui, K. 2002. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J. Am. Soc. Nephrol. 13:866‐874.
   Nakamura, T. , Yonezawa, A. , Hashimoto, S. , Katsura, T. , and Inui, K. 2010. Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin‐induced nephrotoxicity. Biochem. Pharmacol. 80:1762‐1767. doi: 10.1016/j.bcp.2010.08.019
   Obaidat, A. , Roth, M. , and Hagenbuch, B. 2012. The expression and function of organic anion transporting polypeptides in normal tissues and in cancer. Annu. Rev. Pharmacol. Toxicol. 52:135‐151. doi: 10.1146/annurev‐pharmtox‐010510‐100556
   Olarerin‐George, O. and Hogenesch, J.B. 2014. Assessing the prevalence of mycoplasma contamination in cell culture via a survey of NCBI's RNA‐seq archive. bioRxiv doi: http://dx.doi.org/10.1101/007054
   Oswald, S. , Groer, C. , Drozdzik, M. , and Siegmund, W. 2013. Mass spectrometry‐based targeted proteomics as a tool to elucidate the expression and function of intestinal drug transporters. AAPS J. 15:1128‐1140. doi: 10.1208/s12248‐013‐9521‐3
   Pratt, E. , Sissung, T.M. , and Figg, W.D. 2012. Loss of OATP1B3 function causes Rotor syndrome: Implications for potential use of inhibitors in cancer. Cancer Biol. Ther. 13:1374‐1375. doi: 10.4161/cbt.22010
   Sampson, K.E. , Brinker, A. , Pratt, J. , Venkatraman, N. , Xiao, Y. , Blasberg, J. , Steiner, T. , Bourner, M. , and Thompson, D.C. 2015. Zinc finger nuclease‐mediated gene knockout results in loss of transport activity for P‐glycoprotein, BCRP, and MRP2 in Caco‐2 cells. Drug Metab. Dispos. 43:199‐207. doi: 10.1124/dmd.114.057216
   Sekine, T. , Cha, S.H. , and Endou, H. 2000. The multispecific organic anion transporter (OAT) family. Pflugers Arch. 440:337‐350. doi: 10.1007/s004240000297
   Shu, Y. , Brown, C. , Castro, R.A. , Shi, R.J. , Lin, E.T. , Owen, R.P. , Sheardown, S.A. , Yue, L. , Burchard, E.G. , Brett, C.M. , and Giacomini, K.M. 2008. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clin. Pharmacol. Ther. 83:273‐280. doi: 10.1038/sj.clpt.6100275
   Sigel, E. 1990. Use of Xenopus oocytes for the functional expression of plasma membrane proteins. J. Membr. Biol. 117:201‐221. doi: 10.1007/BF01868451
   Stacey, G.N. 1997. Standardization in animal cell technology. Folia Microbiol. 42:113‐116. doi: 10.1007/BF02898717
   Staud, F. , Cerveny, L. , Ahmadimoghaddam, D. , and Ceckova, M. 2013. Multidrug and toxin extrusion proteins (MATE/SLC47); role in pharmacokinetics. Int. J. Biochem. Cell Biol. 45:2007‐2011. doi: 10.1016/j.biocel.2013.06.022
   Stieger, B. and Beuers, U. 2011. The canalicular bile salt export pump BSEP (ABCB11) as a potential therapeutic target. Curr. Drug Targets 12:661‐670. doi: 10.2174/138945011795378496
   Swift, B. , Pfeifer, N.D. , and Brouwer, K.L. 2010. Sandwich‐cultured hepatocytes: An in vitro model to evaluate hepatobiliary transporter‐based drug interactions and hepatotoxicity. Drug Metab. Rev. 42:446‐471. doi: 10.3109/03602530903491881
   Sziraki, I. , Erdo, F. , Beery, E. , Molnar, P.M. , Fazakas, C. , Wilhelm, I. , Makai, I. , Kis, E. , Heredi‐Szabo, K. , Abonyi, T. , Krizbai, I. , Toth, G.K. , and Krajcsi, P. 2011. Quinidine as an ABCB1 probe for testing drug interactions at the blood‐brain barrier: An in vitro in vivo correlation study. J. Biomol. Screen 16:886‐894. doi: 10.1177/1087057111414896
   Tamai, I. , Nezu, J. , Uchino, H. , Sai, Y. , Oku, A. , Shimane, M. , and Tsuji, A. 2000. Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem. Biophys. Res. Commun. 273:251‐260. doi: 10.1006/bbrc.2000.2922
   Uchiumi, T. , Kohno, K. , Tanimura, H. , Hidaka, K. , Asakuno, K. , Abe, H. , Uchida, Y. , and Kuwano, M. 1993. Involvement of protein kinase in environmental stress‐induced activation of human multidrug resistance 1 (MDR1) gene promoter. FEBS Lett. 326:11‐16. doi: 10.1016/0014‐5793(93)81750‐T
   United Nations. 2013. Recommendations on the Transport of Dangerous Goods. Model Regulations, 18th Edition. United Nations, New York.
   Van de Steeg, E. , Stranecky, V. , Hartmannova, H. , Noskova, L. , Hrebicek, M. , Wagenaar, E. , van Esch, A. , de Waart, D.R. , Oude Elferink, R.P. , Kenworthy, K.E. , Sticova, E. , al‐Edreesi, M. , Knisely, A.S. , Kmoch, S. , Jirsa, M. , and Schinkel, A.H. 2012. Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver. J. Clin. Invest. 122:519‐528. doi: 10.1172/JCI59526
   Van Herwaarden, A.E. and Schinkel, A.H. 2006. The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins. Trends Pharmacol. Sci. 27:10‐16. doi: 10.1016/j.tips.2005.11.007
   Volokhov, D.V. , Graham, L.J. , Brorson, K.A. , and Chizhikov, V.E. 2011. Mycoplasma testing of cell substrates and biologics: Review of alternative non‐microbiological techniques. Mol. Cell Probes 25:69‐77. doi: 10.1016/j.mcp.2011.01.002
   Weksler, B. , Romero, I.A. , and Couraud, P.‐O. 2013. The hCMEC/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS 10:16. doi: 10.1186/2045‐8118‐10‐16
   West, K.L. , Ramjiganesh, T. , Roy, S. , Keller, B.T. , and Fernandez, M.L. 2002. 1‐[4‐[4[(4R,5R)‐3,3‐Dibutyl‐7‐(dimethylamino)‐2,3,4,5‐tetrahydro‐4‐hydroxy‐1,1‐di oxido‐1‐benzothiepin‐5‐yl]phenoxy]butyl]‐4‐aza‐1‐azoniabicyclo[2.2.2]octane methanesulfonate (SC‐435), an ileal apical sodium‐codependent bile acid transporter inhibitor alters hepatic cholesterol metabolism and lowers plasma low‐density lipoprotein‐cholesterol concentrations in guinea pigs. J. Pharmacol. Exp. Ther. 303:293‐299. doi: 10.1124/jpet.102.038711
   Wils, P. , Warnery, A. , Phung‐Ba, V. , and Scherman, D. 1994. Differentiated intestinal epithelial cell lines as in vitro models for predicting the intestinal absorption of drugs. Cell Biol. Toxicol. 10:393‐397. doi: 10.1007/BF00755788
   Woodward, O.M. , Kottgen, A. , Coresh, J. , Boerwinkle, E. , Guggino, W.B. , and Kottgen, M. 2009. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc. Natl. Acad. Sci. U.S.A. 106:10338‐10342. doi: 10.1073/pnas.0901249106
   Xia, C.Q. , Milton, M.N. , and Gan, L.S. 2007. Evaluation of drug‐transporter interactions using in vitro and in vivo models. Curr. Drug Metab. 8:341‐363. doi: 10.2174/138920007780655423
   Xiang, X. , Han, Y. , Neuvonen, M. , Pasanen, M.K. , Kalliokoski, A. , Backman, J.T. , Laitila, J. , Neuvonen, P.J. , and Niemi, M. 2009. Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans. Pharmacogenet. Genomics 19:447‐457. doi: 10.1097/FPC.0b013e32832bcf7b
   Ye, D. , Dawson, K.A. , and Lynch, I. 2015. A TEM protocol for quality assurance of in vitro cellular barrier models and its application to the assessment of nanoparticle transport mechanisms across barriers. Analyst 140:83‐97. doi: 10.1039/C4AN01276C
   Yeh, G.C. , Lopaczynska, J. , Poore, C.M. , and Phang, J.M. 1992. A new functional role for P‐glycoprotein: Efflux pump for benzo(a)pyrene in human breast cancer MCF‐7 cells. Cancer Res. 52:6692‐6695.
   Yokoo, S. , Yonezawa, A. , Masuda, S. , Fukatsu, A. , Katsura, T. , and Inui, K. 2007. Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent‐induced nephrotoxicity. Biochem. Pharmacol. 74:477‐487. doi: 10.1016/j.bcp.2007.03.004
   Young, L. , Sung, J. , Stacey, G. , and Masters, J.R. 2010. Detection of Mycoplasma in cell cultures. Nat. Protoc. 5:929‐934. doi: 10.1038/nprot.2010.43
   Yu, M. , Ocana, A. , and Tannock, I.F. 2013. Reversal of ATP‐binding cassette drug transporter activity to modulate chemoresistance: Why has it failed to provide clinical benefit? Cancer Metastasis Rev. 32:211‐227. doi: 10.1007/s10555‐012‐9402‐8
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library